Craig T. Davenport Joins Xhale Innovations as Chief Executive Officer

Share Article

Xhale Innovations, Inc. (XI), a leading medical technology company, announced today that Craig T. Davenport has joined the company as Chief Executive Officer and a member of the Board of Directors.

News Image
Richard Allen, Chairman of the Board of Xhale Innovations, said, “We are thrilled to have such proven leadership and world-class talent at the helm of Xhale Innovations.”

Xhale Innovations, Inc. (XI), a leading medical technology company, announced today that Craig T. Davenport has joined the company as Chief Executive Officer and a member of the Board of Directors.

Mr. Davenport has over 35 years of experience in the health care industry and has a proven track record of leading, building, managing and investing in rapidly growing medical device technology companies. Recently, he was Chairman, President & CEO of Endocare and over six years built the company into a leading provider of minimally invasive technologies to treat prostate, kidney, lung and other cancers using cryotherapy. Earlier in his career, Mr. Davenport was C.O.O & President of Tokos Medical Corporation when it was an early stage medical device manufacturer and clinical services provider, and over nine years he spearheaded the company's growth from a handful of people to more than 3,000 employees, took the Company public in 1990 and grew revenues from $3.7 million to more than $120 million. Mr. Davenport began his career with American Hospital Supply Corporation.

In addition to his management and leadership experience, most recently, Mr. Davenport was CEO & Managing Partner of the D.W. Group a private investment firm he founded in 1993. Over the years the firm has been an active investor in numerous early stage and emerging growth healthcare companies. Some of the investments made through the D. W. Group have included Vescia Medical (sold to Boston Scientific), Sapient Health Network (sold to WebMD), Cohesion Technologies (Sold to AngioTech) and Paradigm Health Services (sold to Inverness Medical).

Richard Allen, Chairman of the Board of Xhale Innovations, said, “We are very excited to have Craig Davenport leading our company, and we are confident he will lead and manage the company into an era of accelerated growth and success. Craig is a seasoned medical device and technology executive with a proven track record of driving growth, operational value and shareholder value. We are thrilled to have such proven leadership and world-class talent at the helm of Xhale Innovations.”

Mr. Davenport will focus on XI’s innovative product line, HyGreen®, a hand hygiene reminder and compliance system which assists healthcare organizations in increasing compliance rates and in so doing, assists in decreasing the rate of healthcare associated infections (HAIs). According to XI CTO, Dr. Richard Melker, “Healthcare associated infections take the lives of nearly 270 people in the U.S. every day and add approximately $30 - 50 billion to U.S. healthcare costs. The Centers for Disease Control and Prevention (CDC) has reported that many of these infections are caused by the lack of hand washing before and after each patient contact. HyGreen® addresses the HAI problem by reminding health-care workers to wash their hands before each and every contact with a patient. Additionally, the HyGreen system provides the hospital with administrative reports and behavioral compliance reporting tools that it can use to work with clinical professionals to improve compliance, reduce infection rates and ultimately, better protect patients from HAIs. HyGreen® was designed to incorporate the recommended hand hygiene guidelines from leading industry experts, including the Association for Professionals in Infection Control and Epidemiology (APIC), the Society for Healthcare Epidemiology of America (SHEA), the Centers for Disease Control and Prevention (CDC) and the Joint Commission Accreditation of Healthcare Organizations (JCAHO).”

"Xhale Innovations and our first system, the HyGreen® system, is very well positioned for dramatic growth”, said Mr. Davenport. “From what we learned with our first customers in 2010, we are ready for rapid national growth during 2011. With our patent pending technology, portfolio of assets, our dedicated employees, a committed and enthusiastic shareholder base and the strong relationships we have developed with our first prestigious hospital customers, we are very excited to enter 2011 which will be our first full year of operation." Our core group of XI employees have accomplished a great deal in a very short period of time. I look forward to working with this core group, and hiring many more employees who will be located across the US to serve our growing base of new customers and insure we exceed our customer's objective to reduce HAIs and improve overall patient care. We truly believe there is an extraordinary opportunity to enhance patient outcomes while creating value for our shareholders - and that proposition has been proven to create significant human and economic value during my career in medical devices.”

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Elena Casson
Visit website